CorMedix Inc.
Status: Publicly traded
Direct answer
CorMedix Inc. is publicly traded on NASDAQ under the ticker CRMD.
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and...
Can you invest in CorMedix Inc.?
Yes. CorMedix Inc. is publicly traded on NASDAQ under the ticker CRMD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CorMedix Inc.
Detailed equity research is provided by MarketSnap.